Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-08-27 15:39:54
Reporting Period:
Filing Date:
Accepted Time:
2012-08-27 15:39:54
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219023 J W David Mcgirr 65 Hayden Avenue
Lexington MA 02421
Svp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-24 20,000 $10.35 37,200 No 4 M Direct
Common Stock Disposition 2012-08-24 20,000 $45.69 17,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2012-08-24 20,000 $0.00 20,000 $10.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2005-09-14 2015-06-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,280 Indirect 401(k) Plan
  1. Sold pursuant to a Rule 10(b)5-1 Plan
  2. This transaction was executed in multiple trades at prices randing from $45.69 to $45.72. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. Option vests 6.25% quarterly over a four-year period.